CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The DDG-MRI project aims to develop a novel imaging technique that uses a deuterium-labeled glucose analogue to provide detailed images of tumors without the ionizing radiation associated with traditional positron emission tomography. This MRI-based method seeks to enhance cancer detection and treatment monitoring whil…
Positron emission tomography (PET) measurements of 2-deoxy-2-[18F]fluoro-D-glucose (FDG) uptake have been widely used clinically for tumour staging, prognosis, and treatment monitoring, where it can be more sensitive at detecting treatment response than magnetic resonance imaging (MRI) and computerised tomography (CT) -based evaluations of tumour size. 2-deoxy-D-glucose (DG) and FDG are non-metabolisable derivatives of D-glucose that get trapped in the cells of active or malignant tissues.
Even…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, LES ULIS
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
TECHNICAL UNIVERSITY OF DENMARK DTU
Denmark, Kongens Lyngby
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Ulm
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, DUSSELDORF
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
